BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15822852)

  • 1. The art of prescribing. Principles of switching novel antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2005; 41(1):45-7. PubMed ID: 15822852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
    Newcomer JW; Campos JA; Marcus RN; Breder C; Berman RM; Kerselaers W; L'italien GJ; Nys M; Carson WH; McQuade RD
    J Clin Psychiatry; 2008 Jul; 69(7):1046-56. PubMed ID: 18605811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel.
    Sullivan G; Bienroth M; Jones M; Millar H; Ratna L; Taylor D
    Curr Med Res Opin; 2007 Jul; 23(7):1733-44. PubMed ID: 17588303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive weight loss in a patient with schizophrenia after switching from olanzapine to aripiprazole. A case report.
    Luebbe G; Kropp S; Harms E; Ziegenbein M
    Pharmacopsychiatry; 2006 Mar; 39(2):76. PubMed ID: 16555168
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.
    L'Italien GJ; Casey DE; Kan HJ; Carson WH; Marcus RN
    J Clin Psychiatry; 2007 Oct; 68(10):1510-6. PubMed ID: 17960964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 9. Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice.
    Newcomer JW; Weiden PJ; Buchanan RW
    J Clin Psychiatry; 2013 Nov; 74(11):1108-20. PubMed ID: 24330898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia.
    Hori H; Nakamura J
    Clin Neuropharmacol; 2014; 37(3):88-9. PubMed ID: 24824665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.
    Ardizzone I; Nardecchia F; Marconi A; Carratelli TI; Ferrara M
    Psychopharmacol Bull; 2010; 43(2):45-66. PubMed ID: 21052042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care maps: atypical antipsychotics. Introduction.
    Houltram B; Scanlan M
    Nurs Stand; 2004 May 19-25; 18(36):42-4. PubMed ID: 15176111
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

  • 15. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
    Suzuki H; Gen K; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):161-8. PubMed ID: 21047544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
    Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
    J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.
    Casey DE; Carson WH; Saha AR; Liebeskind A; Ali MW; Jody D; Ingenito GG;
    Psychopharmacology (Berl); 2003 Apr; 166(4):391-9. PubMed ID: 12610718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant.
    Jones M; Bennett J; Gray R; Arya P; Lucas B
    J Psychiatr Ment Health Nurs; 2006 Feb; 13(1):26-32. PubMed ID: 16441390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.
    Fagiolini A; Brugnoli R; Di Sciascio G; De Filippis S; Maina G
    Expert Opin Pharmacother; 2015 Apr; 16(5):727-37. PubMed ID: 25672664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching and combining antipsychotics.
    Correll CU
    CNS Spectr; 2010 Apr; 15(4 Suppl 6):8-11. PubMed ID: 21141654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.